Bevacizumab

Drug / Medication

The most frequently prescribed oncology drug, which impacts blood vessels in tumors and can prolong survival in colorectal cancer by about 4.5 months when combined with other regimens.

Mentioned in 2 videos

Videos Mentioning Bevacizumab

177 - The development of cancer immunotherapy and its promise for treating advanced cancers

177 - The development of cancer immunotherapy and its promise for treating advanced cancers

Peter Attia MD

The most frequently prescribed oncology drug, which impacts blood vessels in tumors and can prolong survival in colorectal cancer by about 4.5 months when combined with other regimens.

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

Peter Attia MD

An anti-VEGF compound initially approved for colon cancer. It extends survival by only a couple of months at a high cost, leading some countries to refuse to pay for it.